AstraZeneca (AZN)
Health Care · Pharma & Biotech · UK
$187.07
+0.24%
Earnings · last 4 quarters
Q2 2026Jul 27, 2026$1.32$1.25Beat +4.9%$1.32 vs $1.25▲ +0.22%
Q1 2026Apr 29, 2026$1.29$1.27Beat +1.4%$1.29 vs $1.27▼ -0.79%
Beat 2 of 2 · EPS and estimate: Yahoo FinanceEarnings calendar →
About
AstraZeneca plc (AZ) is a Swedish–British multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, England. It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation.
Source: Wikipedia · CC BY-SA 4.0
Sector
Healthcare
Website
www.astrazeneca.comIndex Benchmarks
| Period | AZN | Dow Jones | Nasdaq | S&P 500 |
|---|---|---|---|---|
| 1D | +0.17% | +0.92%(-0.8) | -0.04%(+0.2) | +0.18%(-0.0) |
| 1W | +8.66% | -0.22%(+8.9) | -2.84%(+11.5) | -1.08%(+9.7) |
| 1M | +19.16% | +2.09%(+17.1) | -6.49%(+25.6) | -1.67%(+20.8) |
| YTD | +2.09% | +7.99%(-5.9) | +9.43%(-7.3) | +10.72%(-8.6) |
| 1Y | +14.39% | +10.37%(+4.0) | +6.68%(+7.7) | +10.83%(+3.6) |
Numbers in parentheses show out/underperformance vs the index
Previous Close$186.65
Open$184.59
Day's Range$184.52 - $187.07
52 Week Range$153.41 - $212.71
Volume1.62M
Avg. Volume3.47M
Market Cap$290B
Beta (5Y)0.17
P/E Ratio27.8x
EPS$7.07
P/B Ratio5.77x
Dividend Yield1.15%
Revenue$61B
Net Income$10B
Operating Margin22.1%
Total Debt$32B
Cash$5.0B
1y Target Est$206.66